I. Federal regulations concerning use of asbestos filters in manufacturing parenteral drugs
Casola, A.R.
Bulletin of the Parenteral Drug Association 29(5): 216-218
1975
ISSN/ISBN: 0048-2986 PMID: 1182330 Document Number: 95143
Document emailed within 1 workday
Related Documents
Silant'ev, V.V.; Zaripova, E.P.; Brodilo, L.I. 1992: Work conditions and morbidity of workers at plants manufacturing asbestos-technical products Gigiena i Sanitariia 1: 18-21Izmerov, N.F.; Kovalevskiĭ, E.V. 2004: Regulations of controlled use of asbestos-containing materials in construction industry Meditsina Truda i Promyshlennaia Ekologiia 5: 5-12
Starr, L.M. 1994: CPR, first aid training may not meet expectations of federal regulations Occupational Health and Safety 63(7): 47-8 50 52
Smith, C.E. 1974: New federal regulations for skilled nursing homes Journal of the American Dietetic Association 64(5): 467-469
Ratner, R.E. 1991: Blood glucose testing and federal regulations New England Journal of Medicine 324(9): 635-636
Preslar, M.J. 1973: Conformity of audiometric systems with federal noise regulations North Carolina Medical Journal 34(6): 445-447
Hucke, J. 1982: Implementing Environmental Regulations in the Federal Republic of Germany Policy Studies Journal 11(1): 130-140
Baumgarten, H.J. 1977: Food regulations as regulations to which penalties are attached before and after their transfer to the sphere of regulations governing illegal actions Fleischwirtschaft 57(11): 1984-1988
Tamilvanan, S.; Venkatesh Babu, R.; Kannan, K.; Basu, S.K.; Sa, B. 2008: Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery PDA Journal of Pharmaceutical Science and Technology 62(2): 125-154
Schildge, J.; Pumpe, K.; Ortlieb, H.; Costabel, U. 1990: Bronchial cancer and asbestos: comparison of anamnestic exposure to asbestos, detection of asbestos bodies in bronchoalveolar lavage and in lung tissue Pneumologie 44(Suppl 1): 333-334
Allen, L.V. 1995: Drugs, devices and delivery considerations in parenteral pharmaceutical care, or, what are they doing with our drugs? PDA Journal of Pharmaceutical Science and Technology 49(6): 306-308
McCarthy, C.R. 1995: When OPRR (Office for Protection from Research Risks) comes calling: enforcing Federal research regulations Kennedy Institute of Ethics Journal 5(1): 51-55
Sundaram, S.; Eisenhuth, J.; Howard, G.; Brandwein, H. 2001: Retention of water-borne bacteria by membrane filters. Part III: Bacterial challenge tests on 0.1 micron rated filters PDA Journal of Pharmaceutical Science and Technology 55(2): 114-126
Garfield, F.M. 1970: Federal plan for narcotics and dangerous drugs Bulletin of the Parenteral Drug Association 24(1): 11-13
1982: Regulations for industrial establishments devoted to the manufacture of raw materials for compounding drugs and for laboratories or factories Salud Publica de Mexico 24(2): 212-219
Shepherd, M. 2011: Administration of drugs 3: parenteral Nursing Times 107(36): 16
Sánchez, B.; Rivas, P.; Mario Alvarez, M.; Raimundo García, J. 1989: Tetanus in addicts on parenteral drugs Anales de Medicina Interna 6(8): 448
Walter Wyman and J. G. Carlisle 1897: Circular calling attention to the quarantine regulations to prevent the introduction of plague, and promulgating additional regulations Public Health Reports 12(4): 65-66
McHugh, E.M. 2004: The new EMTALA regulations and the on-call physician shortage: in defense of the regulations Journal of Health Law 37(1): 61-84
Schweitzer, G.E. 1977: Impact of Regulations on R&D: Regulations, Technological Progress, and Societal Interests Research Management 20(2): 13-17